CLARITEV CORP (CTEV) Stock Fundamental Analysis
USA - NYSE:CTEV - US62548M2098 - Common Stock
70.385 USD
+0.7 (+1%)
Taking everything into account, CTEV scores 2 out of 10 in our fundamental rating. CTEV was compared to 35 industry peers in the Health Care Technology industry. CTEV has a bad profitability rating. Also its financial health evaluation is rather negative. CTEV does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
CTEV had negative earnings in the past year.
CTEV had a positive operating cash flow in the past year.
In the past 5 years CTEV reported 4 times negative net income.
Each year in the past 5 years CTEV had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of -13.08%, CTEV perfoms like the industry average, outperforming 51.43% of the companies in the same industry.
CTEV has a Return On Invested Capital of 1.03%. This is in the better half of the industry: CTEV outperforms 68.57% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CTEV is below the industry average of 6.80%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.08% | ||
| ROE | N/A | ||
| ROIC | 1.03% |
ROA(3y)-13.68%
ROA(5y)-9.22%
ROE(3y)-665.39%
ROE(5y)-402.43%
ROIC(3y)2.41%
ROIC(5y)N/A
1.3 Margins
Looking at the Operating Margin, with a value of 6.72%, CTEV is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
In the last couple of years the Operating Margin of CTEV has declined.
CTEV's Gross Margin of 74.43% is fine compared to the rest of the industry. CTEV outperforms 77.14% of its industry peers.
In the last couple of years the Gross Margin of CTEV has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.72% | ||
| PM (TTM) | N/A | ||
| GM | 74.43% |
OM growth 3Y-33.57%
OM growth 5Y-22.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.14%
GM growth 5Y-2.61%
2. Health
2.1 Basic Checks
CTEV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CTEV has about the same amount of shares outstanding.
Compared to 5 years ago, CTEV has less shares outstanding
Compared to 1 year ago, CTEV has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of -0.27, we must say that CTEV is in the distress zone and has some risk of bankruptcy.
CTEV has a Altman-Z score of -0.27. This is comparable to the rest of the industry: CTEV outperforms 48.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.27 |
ROIC/WACC0.14
WACC7.54%
2.3 Liquidity
A Current Ratio of 0.98 indicates that CTEV may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.98, CTEV is doing worse than 77.14% of the companies in the same industry.
CTEV has a Quick Ratio of 0.98. This is a bad value and indicates that CTEV is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.98, CTEV is not doing good in the industry: 77.14% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.98 |
3. Growth
3.1 Past
CTEV shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.25%.
The Revenue has decreased by -2.03% in the past year.
The Revenue has been decreasing by -1.09% on average over the past years.
EPS 1Y (TTM)-0.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.3%
Revenue 1Y (TTM)-2.03%
Revenue growth 3Y-5.92%
Revenue growth 5Y-1.09%
Sales Q2Q%3.47%
3.2 Future
The Earnings Per Share is expected to grow by 25.00% on average over the next years. This is a very strong growth
CTEV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.88% yearly.
EPS Next Y76.94%
EPS Next 2Y35.5%
EPS Next 3Y25%
EPS Next 5YN/A
Revenue Next Year1.46%
Revenue Next 2Y2.57%
Revenue Next 3Y2.88%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CTEV. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CTEV. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
CTEV's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CTEV is cheaper than 82.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 11.39 |
4.3 Compensation for Growth
A more expensive valuation may be justified as CTEV's earnings are expected to grow with 25.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.5%
EPS Next 3Y25%
5. Dividend
5.1 Amount
CTEV does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:CTEV (10/27/2025, 9:36:25 AM)
70.385
+0.7 (+1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners40.19%
Inst Owner ChangeN/A
Ins Owners6.91%
Ins Owner Change5.23%
Market Cap1.16B
Revenue(TTM)935.54M
Net Income(TTM)-663374000
Analysts80
Price Target71.74 (1.93%)
Short Float %8.04%
Short Ratio5.11
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-10.5%
Min EPS beat(2)-23.58%
Max EPS beat(2)2.57%
EPS beat(4)2
Avg EPS beat(4)-19.98%
Min EPS beat(4)-73.58%
Max EPS beat(4)14.65%
EPS beat(8)5
Avg EPS beat(8)-182.55%
EPS beat(12)6
Avg EPS beat(12)-287.29%
EPS beat(16)8
Avg EPS beat(16)-201.21%
Revenue beat(2)2
Avg Revenue beat(2)2.18%
Min Revenue beat(2)1.86%
Max Revenue beat(2)2.51%
Revenue beat(4)2
Avg Revenue beat(4)-0.45%
Min Revenue beat(4)-3.29%
Max Revenue beat(4)2.51%
Revenue beat(8)2
Avg Revenue beat(8)-2.36%
Revenue beat(12)4
Avg Revenue beat(12)-2.64%
Revenue beat(16)6
Avg Revenue beat(16)-2.02%
PT rev (1m)0%
PT rev (3m)124.47%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.65%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.82%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.64%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.3%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.24 | ||
| P/FCF | N/A | ||
| P/OCF | 16.42 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.39 |
EPS(TTM)-40.5
EYN/A
EPS(NY)-11.42
Fwd EYN/A
FCF(TTM)-3.34
FCFYN/A
OCF(TTM)4.29
OCFY6.09%
SpS56.8
BVpS-2.42
TBVpS-273.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.08% | ||
| ROE | N/A | ||
| ROCE | 1.3% | ||
| ROIC | 1.03% | ||
| ROICexc | 1.04% | ||
| ROICexgc | 16.29% | ||
| OM | 6.72% | ||
| PM (TTM) | N/A | ||
| GM | 74.43% | ||
| FCFM | N/A |
ROA(3y)-13.68%
ROA(5y)-9.22%
ROE(3y)-665.39%
ROE(5y)-402.43%
ROIC(3y)2.41%
ROIC(5y)N/A
ROICexc(3y)2.48%
ROICexc(5y)N/A
ROICexgc(3y)66.67%
ROICexgc(5y)N/A
ROCE(3y)3.05%
ROCE(5y)N/A
ROICexgc growth 3Y-40.96%
ROICexgc growth 5Y-27.14%
ROICexc growth 3Y-26.84%
ROICexc growth 5Y-14.89%
OM growth 3Y-33.57%
OM growth 5Y-22.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.14%
GM growth 5Y-2.61%
F-Score4
Asset Turnover0.18
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 9.19 | ||
| Cap/Depr | 28.61% | ||
| Cap/Sales | 13.43% | ||
| Interest Coverage | 0.23 | ||
| Cash Conversion | 14.07% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.98 | ||
| Altman-Z | -0.27 |
F-Score4
WACC7.54%
ROIC/WACC0.14
Cap/Depr(3y)25.06%
Cap/Depr(5y)22.79%
Cap/Sales(3y)10.77%
Cap/Sales(5y)9.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-0.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.3%
EPS Next Y76.94%
EPS Next 2Y35.5%
EPS Next 3Y25%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.03%
Revenue growth 3Y-5.92%
Revenue growth 5Y-1.09%
Sales Q2Q%3.47%
Revenue Next Year1.46%
Revenue Next 2Y2.57%
Revenue Next 3Y2.88%
Revenue Next 5YN/A
EBIT growth 1Y-56%
EBIT growth 3Y-37.5%
EBIT growth 5Y-23.25%
EBIT Next Year145.04%
EBIT Next 3Y35.49%
EBIT Next 5YN/A
FCF growth 1Y-151.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-66.17%
OCF growth 3Y-35.69%
OCF growth 5Y-17.66%
CLARITEV CORP / CTEV FAQ
Can you provide the ChartMill fundamental rating for CLARITEV CORP?
ChartMill assigns a fundamental rating of 2 / 10 to CTEV.
Can you provide the valuation status for CLARITEV CORP?
ChartMill assigns a valuation rating of 1 / 10 to CLARITEV CORP (CTEV). This can be considered as Overvalued.
What is the profitability of CTEV stock?
CLARITEV CORP (CTEV) has a profitability rating of 3 / 10.
Can you provide the expected EPS growth for CTEV stock?
The Earnings per Share (EPS) of CLARITEV CORP (CTEV) is expected to grow by 76.94% in the next year.